日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study

使用 Vivatmo me 设备进行居家 FeNO 监测揭示了不同治疗阶段哮喘患者的 2 型炎症模式:FeNO@Home 研究

Beeh, Kai M; Harrison, Tim; Heffler, Enrico; Timmermann, Hartmut; Weber, Stephan; Wegner, Sandra

Unmet needs of patients with COPD in Germany: a retrospective, cross-sectional study

德国慢性阻塞性肺病患者未满足的需求:一项回顾性横断面研究

Herth, Felix J F; Vogelmeier, Claus F; Trudzinski, Franziska C; Watz, Henrik; Skowasch, Dirk; Beeh, Kai-Michael; Compton, Chris; Mohan, Tharishini; Richter, Hartmut; Claussen, Jing; Bartel, Sabine

Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective

慢性阻塞性肺疾病单吸入器三联疗法与多吸入器三联疗法的成本效益分析:德国医疗保健视角

Beeh, Kai-Michael; Claussen, Jing; Shah, Dhvani; Martin, Alan; Kendall, Robyn; Dasari, Priyadarsini; Ismaila, Afisi S; Noorduyn, Stephen G

Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis

ELLITHE试验中,氟替卡松糠酸酯/乌美溴铵/维兰特罗每日一次单吸入器三联疗法可带来具有临床意义的改善和疾病稳定性:一项事后应答者分析

Beeh, Kai-Michael; Scheithe, Karl; Schmutzler, Heike; Krüger, Saskia

[Use of long-acting triple therapy for chronic obstructive pulmonary disease (COPD) in practice: The ELETHON physicians' survey]

[慢性阻塞性肺疾病(COPD)长效三联疗法在临床实践中的应用:ELETHON 医生调查]

Beeh, Kai-Michael; Krüger, Saskia

How to move towards more sustainable asthma care in Europe: an expert opinion paper

如何在欧洲推进更可持续的哮喘治疗:专家意见文件

Janson, Christer; Wilkinson, Alex; Hisinger-Mölkänen, Hanna; Alcázar Navarrete, Bernardino; Beeh, Kai-Michael; Lavorini, Federico; Kankaanranta, Hannu; Pritchard, John; Suppli Ulrik, Charlotte; Bansal, Aarti; Lähelmä, Satu; Lehtimäki, Lauri

Activation of an atypical plant NLR with an N-terminal deletion initiates cell death at the vacuole

具有 N 端缺失的非典型植物 NLR 的激活会引发液泡中的细胞死亡

Sruthi Sunil, Simon Beeh, Eva Stöbbe, Kathrin Fischer, Franziska Wilhelm, Aron Meral, Celia Paris, Luisa Teasdale, Zhihao Jiang, Lisha Zhang, Moritz Urban, Emmanuel Aguilar Parras, Thorsten Nürnberger, Detlef Weigel, Rosa Lozano-Duran, Farid El Kasmi

CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD

CHF6523 数据表明,磷脂酰肌醇 3-激酶 δ 亚型并非治疗慢性阻塞性肺疾病的合适靶点。

Govoni, Mirco; Bassi, Michele; Girardello, Luca; Lucci, Germano; Rony, François; Charretier, Rémi; Galkin, Dmitry; Faietti, Maria Laura; Pioselli, Barbara; Modafferi, Gloria; Benfeitas, Rui; Bonatti, Martina; Miglietta, Daniela; Clark, Jonathan; Pedersen, Frauke; Kirsten, Anne-Marie; Beeh, Kai-Michael; Kornmann, Oliver; Korn, Stephanie; Ludwig-Sengpiel, Andrea; Watz, Henrik

Antimicrobial and Antibiofilm Activity of Monolaurin against Methicillin-Resistant Staphylococcus aureus Isolated from Wound Infections

月桂酸甘油酯对从伤口感染中分离的耐甲氧西林金黄色葡萄球菌的抗菌和抗生物膜活性

Hassan Abd El-Ghany, Shimaa Salah; Azmy, Ahmed Farag; Osama El-Gendy, Ahmed; Abd El-Baky, Rehab Mahmoud; Mustafa, Ahmad; Abourehab, Mohammed A S; El-Beeh, Mohamed E; Ibrahem, Reham Ali

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial

氟替卡松糠酸酯/乌美溴铵/维兰特罗每日一次单吸入器三联疗法治疗症状性慢性阻塞性肺疾病的真实世界疗效:ELLITHE 非干预性试验

Beeh, Kai-Michael; Scheithe, Karl; Schmutzler, Heike; Krüger, Saskia